Therapeutic protein shake and powder sales grew 14.7% year-on-year, particularly in endocrinology clinics and metabolic care units
Reasons to revisit your dosing plan include: Plateau in weight loss Persistent side effects Changes in lifestyle or health status Transitioning between medications or brands Always make adjustments under the supervision of a medical professional
Individual variation in response Average weight loss numbers obscure tremendous individual variation
"With all of these relatively rare reports, the challenge for the clinicians and patients involved is to figure out is this really a result of a medication or is it an interaction of a variety of different factors," Dr
In many cases, early-stage fatty liver disease is reversible with proper intervention
Key secondary outcomes, including average weight loss (50 lbs vs 33 lbs) and the proportion of participants achieving a weight reduction of 20% or more (48% vs 27%), also favored Zepbound